The use of cytotoxic chemotherapy for cancer therapy has been very suc
cessful in the treatment and often cure of patients with particular ne
oplasms, such as testicular carcinomas and some lymphomas. In addition
, the use of adjuvant chemotherapy in patients whose primary tumor has
been surgically removed contributes significantly to cure rates in so
me of the more common malignancies such as breast carcinoma and colon
cancer. Nonetheless, for most patients with metastatic malignancies, c
urrent antineoplastic drugs provide only brief remissions with few or
no long term cures. In addition, the side effects of therapy lead to s
ubstantial morbidity in nearly all patients. Insights derived from mod
el system studies on two glutathione based lead compounds, TER286 and
TER199, suggest new clinical strategies and raise interesting basic re
search questions regarding the cell biology foundations of cancer chem
otherapy. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.